Trial Profile
A Retrospective Multicentric Cohort Study Evaluating the Efficacy and Safety of the Association of Aflibercept with FOLFIRI3 Regimen as a Second or Later-Line Therapy in Patients with Metastatic Colorectal Cancer (MCRC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Feb 2018
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 21 Feb 2018 New trial record
- 20 Jan 2018 Results presented at the 2018 Gastrointestinal Cancers Symposium.